NRG1 and breast carcinoma: 45K heparin-binding glycoprotein (p45) has similar characteristics to the heregulin proteins that work on HER4 receptor, i.e., proteins’ amino terminal sequence induces differentiation of breast cancer cells and has the ability to activate tyrosine phosphorylation in MDA-MB-453 cells [36].